ReP USP - Resultado da busca

Artigo de periodico
Challenges and future prospects of nanoemulsion as a drug delivery system (2017)
Yukuyama, Megumi Nishitani; Kato, Edna Tomiko Myiake; Loebenberg, Raimar; Bou-Chacra, Nadia Araci
Fonte: Current Pharmaceutical Design. Unidade: FCF
Assuntos: SOLUBILIDADE, NANOTECNOLOGIA, EMULSÕES (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKUYAMA, Megumi Nishitani et al. Challenges and future prospects of nanoemulsion as a drug delivery system. Current Pharmaceutical Design, v. 23, n. 3, p. 495-508, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612822666161027111957. Acesso em: 16 nov. 2025.
APA
Yukuyama, M. N., Kato, E. T. M., Loebenberg, R., & Bou-Chacra, N. A. (2017). Challenges and future prospects of nanoemulsion as a drug delivery system. Current Pharmaceutical Design, 23( 3), 495-508. doi:10.2174/1381612822666161027111957
NLM
Yukuyama MN, Kato ETM, Loebenberg R, Bou-Chacra NA. Challenges and future prospects of nanoemulsion as a drug delivery system [Internet]. Current Pharmaceutical Design. 2017 ; 23( 3): 495-508.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666161027111957
Vancouver
Yukuyama MN, Kato ETM, Loebenberg R, Bou-Chacra NA. Challenges and future prospects of nanoemulsion as a drug delivery system [Internet]. Current Pharmaceutical Design. 2017 ; 23( 3): 495-508.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666161027111957
Artigo de periodico
The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review (2016)
Ghisleni, Daniela Dal Molim ; Braga, M. de Souza; Kikuchi, Irene Satiko ; Brasoveanu, M; Nemtanu, Monica Roxana; Dua, Kamal; Pinto, Terezinha de Jesus Andreoli
Fonte: Current Pharmaceutical Design. Unidade: FCF
Assunto: PLANTAS MEDICINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GHISLENI, Daniela Dal Molim et al. The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review. Current Pharmaceutical Design, v. 22, n. 27, p. 4264-4287, 2016Tradução . . Disponível em: https://doi.org/10.2174/1381612822666160623070829. Acesso em: 16 nov. 2025.
APA
Ghisleni, D. D. M., Braga, M. de S., Kikuchi, I. S., Brasoveanu, M., Nemtanu, M. R., Dua, K., & Pinto, T. de J. A. (2016). The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review. Current Pharmaceutical Design, 22( 27), 4264-4287. doi:10.2174/1381612822666160623070829
NLM
Ghisleni DDM, Braga M de S, Kikuchi IS, Brasoveanu M, Nemtanu MR, Dua K, Pinto T de JA. The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review [Internet]. Current Pharmaceutical Design. 2016 ; 22( 27): 4264-4287.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666160623070829
Vancouver
Ghisleni DDM, Braga M de S, Kikuchi IS, Brasoveanu M, Nemtanu MR, Dua K, Pinto T de JA. The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review [Internet]. Current Pharmaceutical Design. 2016 ; 22( 27): 4264-4287.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666160623070829
Artigo de periodico
Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease (2015)
Maranhão, Raul Cavalcante ; Leite, Antonio Carlos de Arruda
Fonte: Current Pharmaceutical Design. Unidade: FCF
Assuntos: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 16 nov. 2025.
APA
Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714
NLM
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612820666141013150714
Vancouver
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612820666141013150714
Artigo de periodico
Recent advances of radionuclide-based molecular imaging of atherosclerosis (2015)
Kazuma, Soraya Megumi; Sultan, Deborah; Zhao, Yongfeng; Detering, Lisa; You, Meng; Luehmann, Hannah P; Abdalla, Dulcinéia Saes Parra ; Liu, Yongjian
Fonte: Current Pharmaceutical Design. Unidade: FCF
Assuntos: ARTERIOSCLEROSE, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAZUMA, Soraya Megumi et al. Recent advances of radionuclide-based molecular imaging of atherosclerosis. Current Pharmaceutical Design, v. 21, n. 36, p. 5267-5276, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150915104529. Acesso em: 16 nov. 2025.
APA
Kazuma, S. M., Sultan, D., Zhao, Y., Detering, L., You, M., Luehmann, H. P., et al. (2015). Recent advances of radionuclide-based molecular imaging of atherosclerosis. Current Pharmaceutical Design, 21( 36), 5267-5276. doi:10.2174/1381612821666150915104529
NLM
Kazuma SM, Sultan D, Zhao Y, Detering L, You M, Luehmann HP, Abdalla DSP, Liu Y. Recent advances of radionuclide-based molecular imaging of atherosclerosis [Internet]. Current Pharmaceutical Design. 2015 ; 21( 36): 5267-5276.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150915104529
Vancouver
Kazuma SM, Sultan D, Zhao Y, Detering L, You M, Luehmann HP, Abdalla DSP, Liu Y. Recent advances of radionuclide-based molecular imaging of atherosclerosis [Internet]. Current Pharmaceutical Design. 2015 ; 21( 36): 5267-5276.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150915104529
Artigo de periodico
New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches (2014)
Bueno, Renata Vieria; Braga, Rodolpho de Campos; Segretti, Natanael Dante; Ferreira, Elizabeth Igne ; Trossini, Gustavo Henrique Goulart ; Andrade, Carolina Horta
Fonte: Current Pharmaceutical Design. Unidade: FCF
Assuntos: TUBERCULOSE, ÁCIDOS NUCLEICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Renata Vieria et al. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, v. 20, n. 27, p. 4474-4485, 2014Tradução . . Acesso em: 16 nov. 2025.
APA
Bueno, R. V., Braga, R. de C., Segretti, N. D., Ferreira, E. I., Trossini, G. H. G., & Andrade, C. H. (2014). New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, 20( 27), 4474-4485.
NLM
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2025 nov. 16 ]
Vancouver
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2025 nov. 16 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos